Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: COPD Interventions: Combination Product: Test Product - Tiotropium Bromide Inhalation Powder 18 mcg; Combination Product: Spiriva Handihaler (Tiotropium Bromide) 18 mcg; Combination Product: Placebo Sponsors: Xiromed LLC; Exeltis Healthcare S.L; Laboratorios Liconsa SA Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials